Role of Serum Biomarkers in Cancer Patients Receiving Cardiotoxic Cancer Therapies: A Position Statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology
Radek Pudil(Charles University), Alexander R Lyon(Royal Brompton Hospital), Teresa López‐Fernández(Hospital Universitario La Paz), Peter Henriksen, Thomas Suter(University of California San Diego), Frank Ruschitzka(Kantonsspital St. Gallen), Zaza Iakobishvili(Ben-Gurion University of the Negev), Javid J. Moslehi(Cardiovascular Institute of the South), Daniela Cardinale(European Institute of Oncology), Dan Lenihan(Washington University in St. Louis), Ana Barac(Inova Fairfax Hospital), Rudolf A. de Boer(Erasmus MC), Stephan von Haehling(German Centre for Cardiovascular Research), Jelena Čelutkienė(Vilnius University), Susan Dent(Government of the United States of America), Christoph Maack(Universitätsklinikum Würzburg), Andrew J.S. Coats(The Heart Research Institute), Susanna Stanway(Royal Marsden NHS Foundation Trust), Fortunato Ciardiello(University of Campania "Luigi Vanvitelli"), Martin Štěrba(Charles University), Mitja Lainščak, Carlo G. Tocchetti(Federico II University Hospital), Dimitrios Farmakis(National and Kapodistrian University of Athens), Ovidiu Chioncel(Carol Davila University of Medicine and Pharmacy), Eva Haegler‐Laube(University of Bern), Riccardo Asteggiano(University of Insubria), Jutta Bergler‐Klein, Petar Seferović, Jean‐Sébastien Hulot(Inserm), Alain Cohen‐Solal(Inserm), Bonnie Ky(Virginia Commonwealth University), Hadi Skouri(University of Balamand), Massimo Piepoli(University of Milan), Christian Mueller(Immutep (Germany)), Markus S. Anker(Humboldt-Universität zu Berlin), Jereon Bax(Leiden University), Yu. N. Belenkov(Sechenov University)
Cited by 344
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
2016 European Guidelines on cardiovascular disease prevention in clinical practice
|European Heart Journal|2016|6.5k